Giustina Andrea, Porcelli Teresa
Nat Rev Endocrinol. 2009 Aug;5(8):425-7. doi: 10.1038/nrendo.2009.146.
Response to medical therapy for acromegaly is highly variable, with few predictive factors available to help clinicians make informed treatment choices. Researchers in the UK now suggest that prior radiotherapy might influence an individual's response to secondary therapy with dopamine agonists or somatostatin analogs.
肢端肥大症的药物治疗反应差异很大,几乎没有预测因素可帮助临床医生做出明智的治疗选择。英国的研究人员现在表明,既往放疗可能会影响个体对多巴胺激动剂或生长抑素类似物二线治疗的反应。